Skip to main content
YIFAN PHARMACEUTICAL CO.,LTD logo

YIFAN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002019 ISIN · CNE000001K65 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,497 across all filing types
Latest filing 2025-08-14 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002019

About YIFAN PHARMACEUTICAL CO.,LTD

https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative biologics, specialty small molecules, and traditional Chinese medicine. The company maintains a diverse product portfolio, notably featuring Ryzneuta (efbemalenograstim alfa), a long-acting recombinant human granulocyte colony-stimulating factor used to treat chemotherapy-induced neutropenia. It is also recognized as a major global supplier of Vitamin B5 (D-calcium pantothenate). Operating with a global perspective, the firm manages integrated R&D and production platforms that adhere to international quality standards. Its core activities span drug discovery, clinical development, and large-scale manufacturing, with a strategic emphasis on therapeutic areas such as oncology, hematology, and dermatology.

Recent filings

Filing Released Lang Actions
股东会议事规则（2025年8月修订）
Governance Information Classification · 100% confidence The document is titled '股东会议事规则' which translates to 'Rules of Procedure for Shareholders' Meetings'. It contains detailed procedural rules about the convening, proposal submission, notification, holding, supervision, and management of shareholders' meetings. It references relevant laws and regulations governing shareholder meetings and corporate governance. The content is focused on internal governance rules and procedures rather than financial results, audit opinions, or announcements. It does not contain financial statements or earnings data, nor is it an announcement or a transcript. This document fits the description of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2025-08-14 Chinese
内幕信息知情人登记管理制度(2025年8月修订)
Governance Information Classification · 95% confidence The document is titled '内幕信息知情人登记管理制度' which translates to 'Insider Information Insider Registration Management System'. It is a detailed internal policy document outlining the management, registration, and confidentiality of insider information and insider personnel within the company. It includes chapters on definitions, scope, confidentiality, registration procedures, responsibilities, and penalties related to insider information. The document does not contain financial statements, earnings data, or any form of financial results. It is not an announcement or a brief summary but a comprehensive internal governance and compliance policy document. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings as it is not a regulatory announcement or certification. Instead, it aligns with Governance Information (CGR) as it details the company's internal rules and governance practices regarding insider information management.
2025-08-14 Chinese
关联交易决策制度（2025年8月修订）
Governance Information Classification · 95% confidence The document is titled '关联交易决策制度' which translates to 'Related Party Transaction Decision System'. It details the company's policies, procedures, and governance regarding related party transactions, including definitions, decision-making processes, disclosure requirements, and responsibilities. The content is regulatory and governance-focused, outlining internal rules and compliance with relevant laws and stock exchange regulations. It does not contain financial statements, earnings data, or audit results. It is not an announcement or a brief notice but a comprehensive governance document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-14 Chinese
内部控制基本制度（2025年8月修订）
Governance Information Classification · 95% confidence The document is titled '内部控制基本制度' (Internal Control Basic System) and is issued by Yifan Pharmaceutical Co., Ltd. It is a detailed internal control policy document covering governance, risk assessment, control activities, information and communication, internal supervision, and specific risk controls. The content includes company internal control principles, responsibilities of board and management, audit committee roles, risk management, and internal audit procedures. It references compliance with laws and regulations, including securities laws and stock exchange guidelines. The document is comprehensive and regulatory in nature, focusing on internal control systems rather than financial results or external reporting. It does not contain financial statements or earnings data, nor is it an announcement or a brief summary. It is a governance-related document detailing internal rules and control practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length (11,783 characters) supports it being a full policy document rather than a short announcement or certification.
2025-08-14 Chinese
信息披露事务管理制度（2025年8月修订）
Governance Information Classification · 95% confidence The document is titled '信息披露事务管理制度' which translates to 'Information Disclosure Management System'. It extensively details the company's policies, procedures, and responsibilities regarding information disclosure, including definitions of periodic reports (annual, semi-annual, quarterly), temporary reports, disclosure timing, roles of board members and management in disclosure, confidentiality, and compliance with regulatory requirements. It references regulatory frameworks such as the Chinese Securities Law, Shenzhen Stock Exchange rules, and China Securities Regulatory Commission regulations. The document is a comprehensive governance and procedural manual for managing information disclosure rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or audit results but rather outlines the internal rules and governance practices related to disclosure. Therefore, it fits best under Governance Information (CGR).
2025-08-14 Chinese
内部审计制度（2025年8月修订）
Governance Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) and details the internal audit policies, responsibilities, procedures, reporting, and governance within the company. It references relevant laws, regulatory bodies such as the Shenzhen Stock Exchange, and internal control standards. The content is a comprehensive internal audit policy document rather than an audit report or financial statement. It does not contain financial data or audit results but rather the framework and rules governing internal audit activities. Therefore, it is not an Annual Report (10-K), Audit Report (AR), or Interim Report (IR). It is also not a brief announcement or certification. The document fits best under Governance Information (CGR) as it details internal rules, board structure, and governance practices related to internal audit.
2025-08-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.